Lyme Disease Diagnostics Market: By Emerging Diagnostic Technology (Serological Test (ELISA, Western Blot), Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Stanning, Nucleic acid Test), By End-Users (Hospitals, Public/Private Laboratories, Physicians’ Offices) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Lyme Disease Diagnostics Market size was valued at USD 3,564.9 million in 2023 and is poised to grow at a CAGR of 5.7% from 2024 to 2030. Lyme disease is a tick-borne illness caused by Borrelia burgdorferi, characterized by fever, headache, fatigue, and a distinctive erythema migrants rash. If not treated promptly with antibiotics, it can lead to serious complications affecting the joints, heart, and nervous system. According to the Centers for Disease Control and Prevention (CDC), approximately 476,000 Americans are diagnosed and treated for Lyme disease each year. This high disease burden underscores the need for efficient diagnostic tools.

Technological advancements play a crucial role in market expansion, with innovations such as multiplex PCR assays and improved immunoassays enhancing the accuracy and speed of Lyme disease detection. These developments are critical in addressing the challenges of early-stage diagnosis and reducing false-negative results. Furthermore, growing public awareness about the long-term complications of untreated Lyme disease has led to increased demand for testing. This awareness, coupled with expanded healthcare expenditure and a focus on preventive care in many countries, further propels market growth. The market is also benefiting from increased healthcare expenditure and a growing focus on preventive care in many countries. The market faces challenges, including the complexity of lyme disease diagnosis, potential for false-negative results in early stages, and limited healthcare access in some rural endemic areas. Additionally, the high cost of advanced diagnostic equipment and the need for skilled technicians may hinder market growth in certain regions. North America region held the major market share in 2023 and is expected to dominate the global Lyme Disease Diagnostics Market in the forecasted years.

Lyme Disease Diagnostics Market Key Developments:

On April 13, 2022, Quidel Corporation, a healthcare diagnostics company, formed an association with the Bay Area Lyme (BAL) Foundation,

  • Bay Area Lyme (BAL) Foundation is an organization dedicated to making Lyme disease easy to diagnose and simple to cure through research funding and education.
  • Association was formed to educate people about their health, with a specific emphasis on Lyme disease awareness.

Lyme Disease Diagnostics Market Summary

Study Period

N/A

Base Year

2023

CAGR

5.7%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Lyme Disease Diagnostics Market Dynamics

The rising incidence of lyme disease, particularly in endemic regions such as North America and Europe, is a key driver for the Global Lyme Disease Diagnostics Market. Early and accurate diagnosis is crucial for effective treatment and prevention of long-term complications, leading to increased demand for reliable diagnostic tests. The World Health Organization (WHO) estimates that Lyme disease is endemic in over 80 countries worldwide.  Growing public awareness about Lyme disease and its potential consequences has contributed to higher testing rates. Educational campaigns, advocacy groups, and media coverage have played significant roles in informing the public about the importance of early detection. The emergence of more sensitive and specific diagnostic techniques, such as PCR-based tests and advanced immunoassays, has also propelled market growth. However, challenges such as the complexity of Lyme disease diagnosis, potential for false-negative results in early stages, and limited healthcare access in some rural areas where Lyme disease is prevalent may impede market expansion.

Lyme Disease Diagnostics Market Segmentation

By Emerging Diagnostic
  • Serological Test
  • Urine Antigen Tests
  • Lymphocytic Transformation Test
  • Immunofluorescent Staining
  • Nucleic acid Test
By End User
  • Hospitals
  • Public/Private Laboratories
  • Physician’s Office

Frequently Asked Questions

Lyme Disease Diagnostics Market was valued at USD 3,564.9 million in 2023 and is expected to grow at a CAGR 5.7% from 2024 to 2030.

The lyme disease diagnostics market is segmented based on By Emerging Diagnostic Technology, End Users, and Geography.

The leading players in the global Lyme Disease Diagnostics Market are Alere Inc., Canon Life Sciences, T2 Biosystems, Bio Rad Laboratories, Roche Diagnostics International Ltd., Graphene Frontiers, Immunetics Inc., GlaxoSmithKline, Covance Inc., Abbott Laboratories.

Historic years considered for the market study are 2019-2022, 2023 is considered as the base year for market estimation, and Seven years forecast is presented from 2024 – 2030.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Lyme Disease Diagnostics Market Introduction 
2.1.Global Lyme Disease Diagnostics Market  - Taxonomy
2.2.Global Lyme Disease Diagnostics Market  - Definitions
2.2.1.Emerging Diagnostic
2.2.2. End User
2.2.3.Region
3.Global Lyme Disease Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Lyme Disease Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Lyme Disease Diagnostics Market  By Emerging Diagnostic, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Serological Test
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Urine Antigen Tests
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Lymphocytic Transformation Test
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Immunofluorescent Staining
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Nucleic acid Test
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Lyme Disease Diagnostics Market  By  End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Public/Private Laboratories
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Physician’s Office
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Lyme Disease Diagnostics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Lyme Disease Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Emerging Diagnostic Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Serological Test
8.1.2.Urine Antigen Tests
8.1.3.Lymphocytic Transformation Test
8.1.4.Immunofluorescent Staining
8.1.5.Nucleic acid Test
8.2.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Public/Private Laboratories
8.2.3.Physician’s Office
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Lyme Disease Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Emerging Diagnostic Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Serological Test
9.1.2.Urine Antigen Tests
9.1.3.Lymphocytic Transformation Test
9.1.4.Immunofluorescent Staining
9.1.5.Nucleic acid Test
9.2.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Public/Private Laboratories
9.2.3.Physician’s Office
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Lyme Disease Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Emerging Diagnostic Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Serological Test
10.1.2.Urine Antigen Tests
10.1.3.Lymphocytic Transformation Test
10.1.4.Immunofluorescent Staining
10.1.5.Nucleic acid Test
10.2.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Public/Private Laboratories
10.2.3.Physician’s Office
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Lyme Disease Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Emerging Diagnostic Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Serological Test
11.1.2.Urine Antigen Tests
11.1.3.Lymphocytic Transformation Test
11.1.4.Immunofluorescent Staining
11.1.5.Nucleic acid Test
11.2.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Public/Private Laboratories
11.2.3.Physician’s Office
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Lyme Disease Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Emerging Diagnostic Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Serological Test
12.1.2.Urine Antigen Tests
12.1.3.Lymphocytic Transformation Test
12.1.4.Immunofluorescent Staining
12.1.5.Nucleic acid Test
12.2.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Public/Private Laboratories
12.2.3.Physician’s Office
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Alere Inc.
13.2.2.Canon Life Sciences
13.2.3.T2 Biosystems
13.2.4.Bio Rad Laboratories
13.2.5.Roche Diagnostics International Ltd.
13.2.6.Graphene Frontiers
13.2.7.Immunetics Inc.
13.2.8.GlaxoSmithKline
13.2.9.Covance Inc.
13.2.10.Abbott Laboratories
14. Research Methodology 
15. Appendix and Abbreviations 
  • Alere Inc.
  • Canon Life Sciences
  • T2 Biosystems
  • Bio Rad Laboratories
  • Roche Diagnostics International Ltd.
  • Graphene Frontiers
  • Immunetics Inc.
  • GlaxoSmithKline
  • Covance Inc.
  • Abbott Laboratories

Adjacent Markets